S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NYSE:EHCEncompass Health Stock Price, Forecast & News

$65.19
-0.65 (-0.99 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$64.50
Now: $65.19
$66.42
50-Day Range
$59.31
MA: $64.39
$69.72
52-Week Range
$48.01
Now: $65.19
$83.30
Volume589,500 shs
Average Volume779,125 shs
Market Capitalization$6.48 billion
P/E Ratio22.71
Dividend Yield1.72%
Beta0.91
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of February 21, 2019, Encompass Health Corporation operated 130 hospitals, and 278 home health and hospice agencies in 36 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Read More
Encompass Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.47 out of 5 stars


Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone205-967-7116

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.61 billion
Cash Flow$6.00 per share
Book Value$17.17 per share

Profitability

Net Income$358.70 million

Miscellaneous

Employees31,570
Market Cap$6.48 billion
Next Earnings DateN/A
OptionableOptionable
$65.19
-0.65 (-0.99 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Encompass Health (NYSE:EHC) Frequently Asked Questions

How has Encompass Health's stock price been impacted by COVID-19?

Encompass Health's stock was trading at $63.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EHC stock has increased by 2.1% and is now trading at $65.19.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Encompass Health?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Encompass Health
.

How were Encompass Health's earnings last quarter?

Encompass Health Corp (NYSE:EHC) posted its quarterly earnings results on Monday, July, 27th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.39 by $0.08. The business had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.06 billion. Encompass Health had a net margin of 6.21% and a return on equity of 16.89%.
View Encompass Health's earnings history
.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Tuesday, July 21st. Shareholders of record on Thursday, October 1st will be given a dividend of $0.28 per share on Thursday, October 15th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date of this dividend is Wednesday, September 30th.
View Encompass Health's dividend history
.

What price target have analysts set for EHC?

11 brokerages have issued 1 year price targets for Encompass Health's stock. Their forecasts range from $83.00 to $100.00. On average, they anticipate Encompass Health's stock price to reach $91.20 in the next year. This suggests a possible upside of 39.9% from the stock's current price.
View analysts' price targets for Encompass Health
.

Has Encompass Health been receiving favorable news coverage?

Media stories about EHC stock have been trending extremely negative this week, according to InfoTrie. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Encompass Health earned a media sentiment score of -4.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days.
View the latest news about Encompass Health
.

Are investors shorting Encompass Health?

Encompass Health saw a decline in short interest in June. As of June 15th, there was short interest totaling 1,810,000 shares, a decline of 18.5% from the May 31st total of 2,220,000 shares. Based on an average daily trading volume, of 766,000 shares, the short-interest ratio is currently 2.4 days. Currently, 1.9% of the company's stock are sold short.
View Encompass Health's Short Interest
.

Who are some of Encompass Health's key competitors?

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include salesforce.com (CRM), Alibaba Group (BABA), Johnson & Johnson (JNJ), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), CVS Health (CVS), Verizon Communications (VZ), Adobe (ADBE) and Broadcom (AVGO).

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 57)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 57)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres Inpatient Hospitals (Age 53)
  • Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 52)

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $65.19.

How big of a company is Encompass Health?

Encompass Health has a market capitalization of $6.48 billion and generates $4.61 billion in revenue each year. The company earns $358.70 million in net income (profit) each year or $3.91 on an earnings per share basis. Encompass Health employs 31,570 workers across the globe.

What is Encompass Health's official website?

The official website for Encompass Health is www.encompasshealth.com.

How can I contact Encompass Health?

Encompass Health's mailing address is 9001 LIBERTY PARKWAY, BIRMINGHAM AL, 35242. The company can be reached via phone at 205-967-7116 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.